Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, cr foils, and laminates. It also engages in the provision of clinical trial supplies, clinical trial management, and brand protection technologies services; and research and development services comprising formulation stability studies, blister/foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit. Bilcare Limited was incorporated in 1987 and is headquartered in Pune, India.
| Current Price | ₹66.02 |
|---|---|
| Market Cap | ₹155 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services |
| P/E Ratio | 90.4 |
| Return on Equity | -5.21% |
| 52-Week Range | ₹51.62 – ₹75.00 |
| Beta (1Y) | 1.12 |
| Dividend Yield | 0.00% |
Bilcare Ltd. is trading at ₹66.02, with a market capitalisation of ₹155 Cr.
Bilcare Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).
Bilcare Ltd. has a P/E of 90.4 and a return on equity of -5.21%.